hub / portfolio-daily
Snapshot: 08 Sep 2026·20 posiciones

Portfolio Daily

Valor actual
$11,955.59
P&L total
$1,955.59
P&L %
+19.56%
P&L diario
-$122.61
-1.02%
SPY baseline
$718.66
30 Abr 2026
SPY actual
$766.00
+6.59%
Alpha vs SPY
+12.97%
desde baseline
Evolución del portafolio127 días
Composición actual20 posiciones · $1,436.99 cash
NVDA
18.0%$1913
MSFT
15.6%$1658
V
11.3%$1200
LLY
10.3%$1096
JPM
5.8%$614
ABBV
4.3%$461
JNJ
3.6%$380
LMT
3.3%$350
CRM
2.9%$311
BMY
2.8%$301
Otros
22.1%$2344
Trades ejecutadosÚltimos 20 de 161
08 Sep 2026BUYHPE4.3361 @ $55.20 = $239.35

Starter 2%; demanda IA, confirma USD55; target USD65, stop USD50, R/R 1.77:1

08 Sep 2026SELLCVX0.2274 @ $211.59 = $48.12

Profit-take rotacional 25%: retorno +21.58% vs costo; regla de actividad, thesis energy estructural intacta y cash sobre USD500

07 Sep 2026SELLJNJ0.4607 @ $275.23 = $126.81

Profit-take rotacional obligatorio por regla de actividad; retorno previo +15.4%, sin thesis-break; caja para setups con trigger

04 Sep 2026SELLLLY0.3180 @ $1,148.74 = $365.40

TRIM rotacional 25% por regla de actividad; thesis GLP-1 intacta; runner preservado

02 Sep 2026SELLLLY0.4000 @ $1,163.23 = $465.29

TRIM profit-take rotacional 25% de ganadora +15.88%; regla de actividad, thesis GLP-1 intacta, cash sobre piso USD500

01 Sep 2026BUYMSFT0.6100 @ $507.29 = $309.45

ADD MSFT drift close -3.58pp -> -0.84pp; thesis IA/Copilot intacta (Goldman AI capex shocker 2027)

31 Ago 2026SELLMSFT0.9000 @ $513.53 = $0.00
29 Ago 2026BUYAMKR5.1000 @ $47.88 = $244.19

Starter 2%: BofA Buy target USD70, packaging avanzado para IA; stop USD45, R/R 7.7:1.

29 Ago 2026SELLCVX0.3032 @ $201.86 = $61.21

Rotación: recorte 25% de ganadora +15.99% para financiar AMKR; tesis energética intacta.

28 Ago 2026BUYBMY4.5000 @ $66.57 = $299.57

FDA iberdomide (Zenbexus) 13/Ago primer CELMoD mieloma; starter 2.5% target 78 stop 62 R/R 2.5:1

28 Ago 2026SELLMRVL1.0000 @ $221.96 = $221.96

EXIT 100% stop duro 225 roto (marca 221.96, low 219.12) + Reuters 28/Ago dudas timing revenue deal Google (impacto 2029+): tesis warrants/custom silicon invalidada. Cash 778.57 -> 1000.53

28 Ago 2026SELLAMAT0.3700 @ $482.36 = $178.47

TRIM drift rebalance: +1.47pp -> target 2.5%, runner 0.63 sh, cash -> USD778

27 Ago 2026BUYAMAT1.0000 @ $474.71 = $474.71

Starter 3.9% semis equipment: Q3 record + guia Q4 +51% YoY + Goldman top pick; target 560/stop 425

27 Ago 2026SELLMRVL0.5000 @ $241.45 = $120.72

TRIM parcial post-earnings (catalizador consumido); financia starter AMAT

27 Ago 2026BUYCRM1.2000 @ $250.02 = $300.02

CRM starter 2.5%: Q2 beat 26/Ago + FY27 guia subida + read-through NVDA blowout; R/R 7.5:1 stop 230 target 400 (regla actividad 27-Ago)

26 Ago 2026BUYMRVL1.5000 @ $240.99 = $361.49

Entrada starter 3% - earnings 27/Ago + warrants Google USD12.2B, R/R 4.9:1 stop 225

26 Ago 2026SELLABBV0.5990 @ $260.45 = $156.01

TRIM 25% profit-take +22.7% -> rota a MRVL (earnings 27/Ago + warrants Google USD12.2B)

21 Ago 2026BUYGOOGL0.1500 @ $344.77 = $51.72

ADD 21/Ago post-market: cierre drift -0.44pp -> target 2%; Berkshire/Abel top-3 holding US en 13F 14/Ago; AI search+cloud+YouTube PE ~22x. Cash 12.5% sobre piso 00.

19 Ago 2026SELLLLY0.1547 @ $1,277.64 = $197.65

Trim drift +1.62pp -> target 17.5% (Regla C breach +-1.5pp). LLY +5.18% a nuevos maximos: Foundayo oral GLP-1 recetas +14% WoW, guia FY26 raise 5-87B, deal AlzeCure. Profit-take parcial ganador +27% vs cost. Runner 1.6719 sh.

19 Ago 2026SELLAVGO2.2448 @ $362.24 = $813.17

Stop loss Regla B + Regla E 19/Ago 12:00 Arg: Marvell gana deal custom AI chips de Google (warrant $12.2B), tesis custom silicon dañada, stop mental $365 roto, P&L -9.44% vs cost $399.97